![Bettina Cockroft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bettina Cockroft
Direktör/Styrelseledamot på
ANNEXON, INC.
Förmögenhet: 5 $ per 2026-05-31
Profil
Bettina M.
Cockroft is currently an Independent Director at Annexon, Inc. since 2022 and an Independent Director at CNS Pharmaceuticals, Inc. since 2023.
Formerly, served as Chief Medical Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2019 to 2023, Vice President-Clinical Research at Cytokinetics, Inc. from 2017 to 2019, and Chief Medical Officer at Auris Medical AG from 2013 to 2016.
Education includes a doctorate from the University of Genoa and an MBA from MIT Sloan School of Management.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-27 | 1 ( 0 % ) | 5 $ | 2026-05-31 | |
ANNEXON, INC. -.--% | 2026-03-31 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Bettina Cockroft
| Företag | Position | Start |
|---|---|---|
| ANNEXON, INC. | Direktör/Styrelseledamot | 2022-01-20 |
| CNS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2023-05-08 |
Tidigare kända positioner av Bettina Cockroft
| Företag | Position | Slut |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-05-16 |
| CYTOKINETICS, INCORPORATED | Företagsledare/Principal | 2019-09-01 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Teknisk/Vetenskaplig/F&U Direktör | 2016-09-01 |
Bettina Cockrofts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
13
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
University of Genoa
 University of Genoa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
